Pillar Pacific Capital Management’s Myriad Genetics MYGN Stock Holding History

Pillar Pacific Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,400	Closed	-$202K	–	300
2016 Q1	$202K	Hold	5,400	–	–	0.04%	278
2015 Q4	$233K	Hold	5,400	–	–	0.04%	253
2015 Q3	$202K	Buy	+5,400	New	+$192K	0.04%	267
2015 Q2	–	Sell	-5,650	Closed	-$200K	–	295
2015 Q1	$200K	Buy	+5,650	New	+$202K	0.04%	271
2014 Q4	–	Sell	-5,750	Closed	-$222K	–	294
2014 Q3	$222K	Sell	5,750 -100	-2%	-$3.73K	0.04%	260
2014 Q2	$228K	Hold	5,850	–	–	0.04%	272
2014 Q1	$200K	Buy	+5,850	New	+$181K	0.04%	281

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Pillar Pacific Capital Management's MYGN Position: Q2 2016 in Review

Pillar Pacific Capital Management sold out of Myriad Genetics (MYGN) in Q2 2016, closing a stake of 5,400 shares — an estimated $202K sold.

Pillar Pacific Capital Management first reported a position in MYGN in Q1 2014 and held it in 7 quarters. The position peaked at $233K in Q4 2015. 252 funds tracked by Wall St. Rank hold MYGN as of Q2 2016.

Pillar Pacific Capital Management reported no remaining Myriad Genetics position as of Q2 2016 after selling out during the quarter.
Pillar Pacific Capital Management sold 5,400 Myriad Genetics shares in Q2 2016, an estimated $202K.
Pillar Pacific Capital Management first reported a position in Myriad Genetics in Q1 2014 and held it in 7 quarters.
Pillar Pacific Capital Management's Myriad Genetics position peaked at $233K in Q4 2015.
252 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2016.

Based on Pillar Pacific Capital Management's 13F filing for Q2 2016, filed 1 Aug 2016.